Collateral Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Tuberculosis Control in Jiangsu Province, China
Qiao Liu, Peng Lü, Ye Shen, Changwei Li, Jianming Wang, Limei Zhu, Wei Lu, Leonardo Martínez
Abstract
The coronavirus disease 2019 (COVID-19) pandemic may impede global tuberculosis elimination goals. In Jiangsu Province, China, tuberculosis notifications dropped 52% in 2020 compared to 2015-2019. Treatment completion and screening for drug resistance decreased continuously in 2020. Urgent attention must be paid to tuberculosis control efforts during and after the COVID-19 pandemic.
Topics & Concepts
PandemicMedicineCoronavirus disease 2019 (COVID-19)TuberculosisCoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ChinaDisease2019-20 coronavirus outbreakCollateral damageVirologyEnvironmental healthInfectious disease (medical specialty)OutbreakInternal medicineGeographyPathologySociologyCriminologyArchaeologyTuberculosis Research and EpidemiologyCOVID-19 Clinical Research StudiesDiagnosis and treatment of tuberculosis